LUFENURON — all Canadian products
12 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is LUFENURON, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02238928 | PROGRAM | ELANCO CANADA LIMITED | Tablet | Oral | LUFENURON 90 MG | Cancelled Post Market | |
| 02238927 | PROGRAM | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | Oral | LUFENURON 45 MG | Cancelled Post Market | |
| 02238926 | PROGRAM | ELANCO CANADA LIMITED | Tablet | Oral | LUFENURON 409.8 MG | Cancelled Post Market | |
| 02238925 | PROGRAM | ELANCO CANADA LIMITED | Tablet | Oral | LUFENURON 204.9 MG | Cancelled Post Market | |
| 02237517 | PROGRAM 40 | ELANCO CANADA LIMITED | Suspension | Subcutaneous | LUFENURON 40 MG | Cancelled Post Market | |
| 02237516 | PROGRAM 80 | ELANCO CANADA LIMITED | Suspension | Subcutaneous | LUFENURON 80 MG | Cancelled Post Market | |
| 02057832 | PROGRAM SUSPENSION | ELANCO CANADA LIMITED | Suspension | Oral | LUFENURON 133 MG | Cancelled Post Market | |
| 02192632 | PROGRAM SUSPENSION | ELANCO CANADA LIMITED | Suspension | Oral | LUFENURON 266 MG | Cancelled Post Market | |
| 02087359 | PROGRAM TABLETS 204.9MG | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | Oral | LUFENURON 204.9 MG | Cancelled Post Market | |
| 02087367 | PROGRAM TABLETS 409.8MG | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | Oral | LUFENURON 409.8 MG | Cancelled Post Market | |
| 02087332 | PROGRAM TABLETS 45MG | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | Oral | LUFENURON 45 MG | Cancelled Post Market | |
| 02087340 | PROGRAM TABLETS 90MG | NOVARTIS ANIMAL HEALTH CANADA INC | Tablet | Oral | LUFENURON 90 MG | Cancelled Post Market |
Browse other molecules: